Triple Negative Breast Cancer, Oncologist Fabi: •New Options Already From the First Line of Cure •
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.7 Articles
7 Articles
Triple Negative Breast Cancer, Fabi (Gemelli) 'New Options Already From the First Line of Treatment'
At the Congress Esmo 2026 in Madrid, new data from the Ascent-03 and Ascent-04 studies were presented, dedicated to patients with triple negative breast cancer in advanced stage at the first relapse. The two studies evaluate sacituzumab govitecan compared to standard chemotherapy." Thus at the Adnkronos Salute Alessandra Fabi, responsible for the Unit of Precision Medicine in Senology at the Fondazione Policlinico Universitario A. Gemelli Irccs …
The triple negative breast cancer represents about 15-17% of all breast cancers and is characterized by the absence of estrogen, progesterone and Her2 receptors. New data from the Ascent-03 and Ascent-04 studies have been presented at the Esmo 2026 Congress in Madrid, dedicated to patients with this advanced stage cancer at the... Read more L'articolo Three-negative breast cancer, oncologist Fabi: "New options already from the first line of trea…
newsbiella.it
Giornale Radio(Adnkronos) - Triple negative breast cancer "represents about 15-17% of all breast cancers and is characterized by the absence of estrogen, progesterone and Her2 receptors. At the Congress Esmo 2026 in Madrid...
notizie.it
Rec News | Lontani dal mainstream(Adnkronos) - Triple negative breast cancer "represents about 15-17% of all breast cancers and is characterized by the absence of receptors
Coverage Details
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
